Literature DB >> 22308478

Hallucinogen actions on human brain revealed.

Hyeong-Min Lee1, Bryan L Roth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22308478      PMCID: PMC3277578          DOI: 10.1073/pnas.1121358109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  14 in total

1.  Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells.

Authors:  G K Aghajanian; G J Marek
Journal:  Neuropharmacology       Date:  1997 Apr-May       Impact factor: 5.250

2.  Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.

Authors:  Javier González-Maeso; Noelia V Weisstaub; Mingming Zhou; Pokman Chan; Lidija Ivic; Rosalind Ang; Alena Lira; Maria Bradley-Moore; Yongchao Ge; Qiang Zhou; Stuart C Sealfon; Jay A Gingrich
Journal:  Neuron       Date:  2007-02-01       Impact factor: 17.173

3.  Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex.

Authors:  Jean-Claude Béïque; Mays Imad; Ljiljana Mladenovic; Jay A Gingrich; Rodrigo Andrade
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

4.  Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors.

Authors:  M Victoria Puig; Akiya Watakabe; Mika Ushimaru; Tetsuo Yamamori; Yasuo Kawaguchi
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

5.  5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites.

Authors:  R L Jakab; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

6.  Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.

Authors:  R A Glennon; M Titeler; J D McKenney
Journal:  Life Sci       Date:  1984-12-17       Impact factor: 5.037

7.  Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex.

Authors:  J de Almeida; G Mengod
Journal:  J Neurochem       Date:  2007-07-17       Impact factor: 5.372

8.  Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

Authors:  Bryan L Roth; Karen Baner; Richard Westkaemper; Daniel Siebert; Kenner C Rice; SeAnna Steinberg; Paul Ernsberger; Richard B Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

9.  Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.

Authors:  Robin L Carhart-Harris; David Erritzoe; Tim Williams; James M Stone; Laurence J Reed; Alessandro Colasanti; Robin J Tyacke; Robert Leech; Andrea L Malizia; Kevin Murphy; Peter Hobden; John Evans; Amanda Feilding; Richard G Wise; David J Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

10.  Htr2a Gene and 5-HT(2A) Receptor Expression in the Cerebral Cortex Studied Using Genetically Modified Mice.

Authors:  Elaine T Weber; Rodrigo Andrade
Journal:  Front Neurosci       Date:  2010-08-13       Impact factor: 4.677

View more
  8 in total

Review 1.  Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.

Authors:  Susan Ling; Felicia Ceban; Leanna M W Lui; Yena Lee; Kayla M Teopiz; Nelson B Rodrigues; Orly Lipsitz; Hartej Gill; Mehala Subramaniapillai; Rodrigo B Mansur; Kangguang Lin; Roger Ho; Joshua D Rosenblat; David Castle; Roger S McIntyre
Journal:  CNS Drugs       Date:  2021-11-17       Impact factor: 5.749

Review 2.  Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.

Authors:  Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2013-03       Impact factor: 6.186

3.  DARK Classics in Chemical Neuroscience: NBOMes.

Authors:  Christian B M Poulie; Anders A Jensen; Adam L Halberstadt; Jesper L Kristensen
Journal:  ACS Chem Neurosci       Date:  2019-11-12       Impact factor: 5.780

4.  Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia.

Authors:  Berit Brogaard
Journal:  Front Hum Neurosci       Date:  2013-10-21       Impact factor: 3.169

Review 5.  Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.

Authors:  Paul Cumming; Milan Scheidegger; Dario Dornbierer; Mikael Palner; Boris B Quednow; Chantal Martin-Soelch
Journal:  Molecules       Date:  2021-04-22       Impact factor: 4.411

6.  Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT2A Receptor Agonists.

Authors:  Christian B M Poulie; Eline Pottie; Icaro A Simon; Kasper Harpsøe; Laura D'Andrea; Igor V Komarov; David E Gloriam; Anders A Jensen; Christophe P Stove; Jesper L Kristensen
Journal:  J Med Chem       Date:  2022-09-13       Impact factor: 8.039

7.  Traditional medicines and globalization: current and future perspectives in ethnopharmacology.

Authors:  Marco Leonti; Laura Casu
Journal:  Front Pharmacol       Date:  2013-07-25       Impact factor: 5.810

8.  What Can Neuroscience Tell Us about the Hard Problem of Consciousness?

Authors:  Berit Brogaard; Dimitria Electra Gatzia
Journal:  Front Neurosci       Date:  2016-09-07       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.